Heron Therapeutics
HRTX
HRTX
189 hedge funds and large institutions have $1.61B invested in Heron Therapeutics in 2021 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 65 increasing their positions, 48 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2.29% more ownership
Funds ownership: 99.71% → 102% (+2.3%)
2% less funds holding
Funds holding: 193 → 189 (-4)
10% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 39
Holders
189
Holding in Top 10
3
Calls
$6.24M
Puts
$3.78M
Top Buyers
| 1 | +$123M | |
| 2 | +$33.2M | |
| 3 | +$32.6M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$22.8M |
| 5 |
JPMorgan Chase & Co
New York
|
+$19.2M |
Top Sellers
| 1 | -$55.7M | |
| 2 | -$25.2M | |
| 3 | -$11.1M | |
| 4 |
Goldman Sachs
New York
|
-$8.26M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$8.24M |